A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
for Small Cell Lung Cancer
Drug: Atezolizumab
Sites in Fairfax +10 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07155174·Phase 2·Recruiting·Listed Sep 2025